Tag: Psilocybin
-
![Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser]()
Lucy Loves Luchre: Psyence Group (PSYG.C) was always just a shroom chaser
The boss has told me to start running the rule over weed and psychedelics companies with a view to picking out anything that’s quietly profitable, or could be soon, among the general dross of both sectors, and to say I’m excited by that would be an overstatement. In general, cannabis companies are hamstrung by government…
-
![Pubco cocaine is here: What does it mean, who’s in, and who’s real?]()
Pubco cocaine is here: What does it mean, who’s in, and who’s real?
I recently listened to a podcast episode of Search Engine with PJ Vogt, and I REALLY got into it. The episode was titled, “Why are drug dealers putting fentanyl in everything?” I’d asked myself the same question many times – why kill your customers? I’d recommend you go listen because the answer is a lot…
-
![Today’s Idea: Filament Health’s (FH.NE) psychedelics play]()
Today’s Idea: Filament Health’s (FH.NE) psychedelics play
Our Psychedelic Trip Isn’t Over I don’t know the first thing about psychedelics. Rather, that’s what I would have been saying back in 2020 when the psychedelics sector was experiencing an unprecedented breakout period. Maybe it was because of mainstream media or perhaps it was my nagging parents, but I have always feared psychedelics. Back…
-
![Filament Health (FH.NEO) is doing the work to stand out in the psychedelics sector]()
Filament Health (FH.NEO) is doing the work to stand out in the psychedelics sector
I’ll admit that I’m beginning to have my suspicions about the psychedelic sector. The question I’ve started asking when I look at a new psychedelics company is where’s the evidence that they’re actually serious about getting products on shelves? How many startup drug companies at will never see the inside of a laboratory? Why? The…
-
![Filament Health (FH.NEO): fighting the good fight against anxiety and depression]()
Filament Health (FH.NEO): fighting the good fight against anxiety and depression
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…
-
![Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety]()
Filament Health (FH.NEO) brings an all natural option to fight depression and anxiety
You’d be hard pressed to find someone who hasn’t been touched by depression or anxiety. Biochemically, they’re considered co-morbid, which means they often happen at the same time and feed off of one another. Depression and anxiety often overlap in terms of neurotransmitters and therefore, they’re often lumped together and treated the same way. And…
-
![Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours]()
Today’s Idea: Revive Therapeutics (RVV.C) offers treatments for a mixed-bag of diseases, but the upside is all yours
We’re closing in on three years now and it’s becoming hard to believe there was a market before COVID-19. We can barely remember it. Cannabis was a thing briefly, and before that we had crypto, and after cannabis’ untimely deflation in the summer of 2018, we were looking for the next source of market exuberance.…
-
Psychedelic Weekly Roundup with MNMD.Q, MSET.C, MYND.C, MEDI.NE, AWKN.NE, SILO, MCUR.C, NOVA.C, TRYP.C, TPIA, NEON.C
Another busy week in the psychedelic sector, with many smaller companies not always covered here at Equity Guru making news. Let’s start with the biggest players though. Mind Medicine (MNMD.Q, MMED.NE) MindMed announced that they have agreed to partner with Forian (FORA.Q), who provide evidence-based support for clinical and commercial decision making. Forian and MindMed will collaborate to…
-
![Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q]()
Psyched for this weeks news from CYBN.NE, PSYC.C, MNMD.Q, MSET.C, FTRP.Q, MYCO.NE, RVV.C, FH.NE, CMND.C, ATAI.Q
This week, news from the psychedelic sector has been dominated by patent applications and earnings being released. Here’s the run down of this week’s news. Cybin (CYBN.NE) It’s been a busy week for Cybin. Last week, after market close, they released their financials for the quarter ending on June 30, 2021, which showed they had…
-
![Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor]()
Filament Health (FH.NE) releases financials for Q2 of 2021, Tom Kineshanko transitioning from President to Founding Advisor
Filament Health (FH.NE) to release their unaudited financial results for the second quarter of 2021, a period that ended June 30, 2021. As of June 30, Filament had $7.8 million in cash and cash equivalents. This includes $5 million which was raised through a private placement that closed on June 21. That private placement included…
